Hoberman Kenneth
Chief Operating Officer at STEMLINE THERAPEUTICS INC
- Sold, on record
- $5.8M
- Dollars the filings state
- Form 4 sales
- 28
- Latest Mar 10, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STEMLINE THERAPEUTICS INCChief Operating Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMar 12, 2019 2019
Sold 26,082 shares at $11.11 ($290k)
Hoberman Kenneth, Chief Operating Officer
Sold 3.3% of holdings ($8.7M position)755,696 shares left2.3x usual sizeFiling
- 2 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMay 14, 2019 +63 days
Sold 25,817 shares at $14.27 ($368k)
Hoberman Kenneth, Chief Operating Officer
Sold 3.4% of holdings ($10.8M position)729,879 shares left2.2x usual sizeFiling
- 3 Form 4 sale STEMLINE THERAPEUTICS INCUnusualJun 26, 2019 +43 days
Sold 47,115 shares at $15.07 ($710k)
Hoberman Kenneth, Chief Operating Officer
Sold 6.5% of holdings ($11M position)682,764 shares left3.7x usual sizeFiling
- 4 Form 4 sale STEMLINE THERAPEUTICS INCUnusualDec 27, 2019 +184 days
Sold 46,312 shares at $10.84 ($502k)
Hoberman Kenneth, Chief Operating Officer
Sold 6.8% of holdings ($7.4M position)636,452 shares left3.4x usual sizeFiling
- 5 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedJan 8, 2020 +12 days
Sold 13,228 shares at $10.37 ($137k)
Hoberman Kenneth, Chief Operating Officer
Sold 2.1% of holdings ($6.6M position)623,224 shares left0.9x usual sizeFiling
- 6 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedJan 22, 2020 +14 days
Sold 22,139 shares at $7.02 ($155k)
Hoberman Kenneth, Chief Operating Officer
Sold 3.6% of holdings ($4.4M position)601,085 shares left1.6x usual sizeFiling
- 7 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedFeb 25, 2020 +34 days
Sold 11,547 shares at $6.42 ($74k)
Hoberman Kenneth, Chief Operating Officer
Sold 1.4% of holdings ($5.2M position)797,955 shares left0.5x usual sizeFiling
- 8 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMar 10, 2020 +14 days
Sold 26,191 shares at $4.97 ($130k)
Hoberman Kenneth, Chief Operating Officer
Sold 3.3% of holdings ($4M position)771,764 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2020 | Mar 13, 2020 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 26,191 | $130k | 3.3% | Plan not stated | SEC |
| Feb 25, 2020 | Feb 28, 2020 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 11,547 | $74k | 1.4% | Plan not stated | SEC |
| Jan 22, 2020 | Jan 24, 2020 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 22,139 | $155k | 3.6% | Plan not stated | SEC |
| Jan 8, 2020 | Jan 10, 2020 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 13,228 | $137k | 2.1% | Plan not stated | SEC |
| Dec 27, 2019 | Jan 3, 2020 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 46,312 | $502k | 6.8% | Unusual | SEC |
| Jun 26, 2019 | Jun 28, 2019 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 47,115 | $710k | 6.5% | Unusual | SEC |
| May 14, 2019 | May 17, 2019 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 25,817 | $368k | 3.4% | Plan not stated | SEC |
| Mar 12, 2019 | Mar 15, 2019 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 26,082 | $290k | 3.3% | Plan not stated | SEC |
| Mar 7, 2019 | Mar 8, 2019 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 2,995 | $34k | 0.4% | Plan not stated | SEC |
| Feb 25, 2019 | Feb 27, 2019 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 10,557 | $127k | 1.3% | Plan not stated | SEC |
| Jan 8, 2019 | Jan 11, 2019 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 13,547 | $138k | 2.1% | Plan not stated | SEC |
| Nov 26, 2018 | Nov 30, 2018 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 26,296 | $312k | 3.8% | Unusual | SEC |
| Mar 13, 2018 | Mar 14, 2018 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 29,987 | $514k | 6.8% | Unusual | SEC |
| Mar 7, 2018 | Mar 9, 2018 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 3,027 | $50k | 0.8% | Plan not stated | SEC |
| Feb 27, 2018 | Feb 28, 2018 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 11,026 | $192k | 2.9% | Plan not stated | SEC |
| Feb 15, 2018 | Feb 16, 2018 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 1,851 | $29k | 0.5% | Plan not stated | SEC |
| Jan 8, 2018 | Jan 12, 2018 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 14,040 | $196k | 3.5% | Unusual | SEC |
| Dec 18, 2017 | Dec 19, 2017 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 11,983 | $170k | 2.9% | Unusual | SEC |
| Mar 7, 2017 | Mar 9, 2017 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 2,342 | $19k | 0.8% | Plan not stated | SEC |
| Feb 28, 2017 | Mar 1, 2017 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 8,027 | $56k | 2.8% | Unusual | SEC |
| Feb 16, 2017 | Feb 17, 2017 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 1,508 | $10k | 0.5% | Plan not stated | SEC |
| Jan 10, 2017 | Jan 13, 2017 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 9,110 | $126k | 3.1% | Unusual | SEC |
| Mar 8, 2016 | Mar 10, 2016 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 2,412 | $13k | 0.8% | Plan not stated | SEC |
| Feb 17, 2016 | Feb 19, 2016 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 1,503 | $7k | 0.7% | Plan not stated | SEC |
| Mar 19, 2015 | Mar 20, 2015 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 17,307 | $284k | 12.4% | Plan not stated | SEC |
| Feb 18, 2015 | Feb 20, 2015 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 1,593 | $22k | 1.8% | Plan not stated | SEC |
| May 21, 2014 | May 23, 2014 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 15,250 | $203k | 14.8% | Plan not stated | SEC |
| Nov 27, 2013 | Nov 27, 2013 | STEMLINE THERAPEUTICS INC | Chief Operating Officer | Form 4 sale | 44,428 | $921k | 33.6% | Unusual | SEC |